Friday, October 20, 2023 12:24:12 PM
According to data from Benzinga Pro, more than 45 million shares have already been traded in the session, compared to the stock's 100-day average of just over 200 thousand shares.
Xortx Therapeutics is a clinical-stage biotechnology company focused on identifying, developing, and commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan disease indications such as ADPKD and T2DN, as well as AKI associated with respiratory virus infection.
Related News: What's Going On With Bitcoin Mining Stocks Marathon Digital And Riot Platforms?
XRTX Price Action: According to Benzinga Pro, Xortx Therapeutics shares are up 52% at 53 cents at the time of publication.
New York Yankees and Duke Basketball
Recent XRTX News
- Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 08:10:54 PM
- XORTX Reprices Warrants Issued in Connection with Previous Private Placements • GlobeNewswire Inc. • 04/30/2024 05:54:49 PM
- XORTX Announces Publication of Key Research in ADPKD • GlobeNewswire Inc. • 04/22/2024 11:00:00 AM
- XORTX Welcomes New Member to the Board of Directors • GlobeNewswire Inc. • 04/08/2024 11:30:00 AM
- XORTX Announces Participation in Spring 2024 Investor Conferences • GlobeNewswire Inc. • 04/08/2024 11:00:00 AM
- XORTX Announces New Clinical Advisory Board Member • GlobeNewswire Inc. • 03/27/2024 09:00:00 AM
- XORTX Highlights Achievements of 2023 and Preparation for Registration Clinical Trial • GlobeNewswire Inc. • 03/19/2024 09:00:00 AM
- XORTX Reprices Warrants Issued in Connection with Previous Private Placements • GlobeNewswire Inc. • 03/11/2024 11:00:00 AM
- XORTX Finalizes $2.7 Million Prospectus Supplement and Concurrent Private Placement for the Offering of Units • GlobeNewswire Inc. • 03/04/2024 12:00:00 PM
- XORTX Raises $2.5 Million Under Prospectus Supplement and Concurrent Private Placement for the Offering of Units • GlobeNewswire Inc. • 02/15/2024 12:00:00 PM
- XORTX Files an Amended and Restated Prospectus Supplement for the Offering of Units • GlobeNewswire Inc. • 02/02/2024 01:46:09 AM
- XORTX Announces $2 Million Public Offering • GlobeNewswire Inc. • 01/15/2024 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/03/2024 12:25:58 PM
- XORTX Submits a New Patent for the Treatment of Chronic Kidney Disease • GlobeNewswire Inc. • 01/03/2024 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/02/2024 01:12:44 PM
- XORTX Welcomes New Member to the Board of Directors • GlobeNewswire Inc. • 01/02/2024 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/30/2023 09:04:02 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/30/2023 12:30:05 PM
- XORTX Announces US ATM Offering • GlobeNewswire Inc. • 11/30/2023 12:30:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/30/2023 02:57:42 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/29/2023 12:00:05 PM
- XORTX Meets Nasdaq Continued Listing Requirements • GlobeNewswire Inc. • 11/29/2023 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/13/2023 12:00:11 PM
- XORTX Clarifies Timing for Share Consolidation • GlobeNewswire Inc. • 11/10/2023 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/08/2023 10:00:08 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM